Globus Medical price target raised to $92 from $80 at Stifel
The Fly

Globus Medical price target raised to $92 from $80 at Stifel

Stifel analyst Mathew Blackman raised the firm’s price target on Globus Medical (GMED) to $92 from $80 and keeps a Buy rating on the shares. Q3 “served as another, significant confirmation” of the firm’s thesis that the business is on more-solid footing today than most expected, the analyst tells investors. From here, the firm thinks estimates are “too low” and the multiple “can see 1-2 turns higher” the analyst added.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App